Understanding and reducing HIV risk in older populations during the COVID-19 pandemic.
The changing face of HIV in the era of COVID-19: Maximising HIV incidence reduction through dynamic targeting of current and future distributions of acquisition risk.
['FUNDING_R01'] · STELLENBOSCH UNIVERSITY · NIH-11001508
This study looks at how the COVID-19 pandemic has changed the way HIV spreads, especially among older people in South Africa, and aims to find new ways to help prevent infections in rural communities.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | STELLENBOSCH UNIVERSITY (nih funded) |
| Locations | 1 site (Stellenbosch, SOUTH AFRICA) |
| Trial ID | NIH-11001508 on ClinicalTrials.gov |
What this research studies
This research investigates how the COVID-19 pandemic has affected HIV transmission dynamics, particularly among older populations in South Africa. By analyzing data from a large population-based HIV cohort, the study aims to identify emerging vulnerable groups and develop targeted prevention strategies. The approach includes assessing the impact of new antiretroviral treatments and disruptions in healthcare services on HIV incidence. The goal is to create effective interventions that can be implemented in rural communities to reduce new infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 65 and older living in rural areas of South Africa who may be at risk for HIV.
Not a fit: Patients under the age of 65 or those not residing in the targeted rural communities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective HIV prevention strategies tailored for older adults, ultimately reducing new infections in this vulnerable population.
How similar studies have performed: Previous research has shown success in targeted HIV prevention strategies, but this specific approach focusing on older populations during the COVID-19 pandemic is relatively novel.
Where this research is happening
Stellenbosch, SOUTH AFRICA
- STELLENBOSCH UNIVERSITY — Stellenbosch, SOUTH AFRICA (ACTIVE)
Researchers
- Principal investigator: TANSER, FRANK COURTENEY — STELLENBOSCH UNIVERSITY
- Study coordinator: TANSER, FRANK COURTENEY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus